Ligand Pharmaceuticals
LGND
#2805
Rank
A$8.61 B
Marketcap
A$431.92
Share price
2.31%
Change (1 day)
55.44%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): A$0.36 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.29 Billion. In 2025 the company made an earning of A$0.23 Billion, an increase over its 2024 earnings that were of A$7.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.36 B55.97%
2025 A$0.23 B2848.57%
2024 A$7.94 M-91.37%
2023 A$92.04 M-7.59%
2022 A$99.6 M4%
2021 A$95.77 M296.42%
2020 A$24.15 M-97.97%
2019 A$1.19 B275.62%
2018 A$0.31 B237.48%
2017 A$93.97 M49.05%
2016 A$63.04 M55.41%
2015 A$40.56 M36.87%
2014 A$29.63 M29.59%
2013 A$22.87 M1309.35%
2012 A$1.62 M-43.97%
2011 A$2.89 M-113.19%
2010 -A$21.97 Million59.86%
2009 -A$13.74 Million-61.33%
2008 -A$35.53 Million-58.75%
2007 -A$86.12 Million20.52%
2006 -A$71.46 Million81.27%
2005 -A$39.42 Million
2003 -A$27.45 Million-20.6%
2002 -A$34.57 Million4.38%
2001 -A$33.12 Million-48.83%
2000 -A$64.71 Million-19.74%
1999 -A$80.63 Million-19.06%
1998 -A$99.61 Million126.71%
1997 -A$43.94 Million-5.83%
1996 -A$46.66 Million136.23%
1995 -A$19.75 Million-33.97%
1994 -A$29.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.50 B 10,634.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.88 B 2,728.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.07 B 13,660.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.72 B 4,113.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.7 Billion-297.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.00 B 3,049.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.04 B 4,778.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$11.29 B 3,131.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$88.56 Million-125.35%๐Ÿ‡บ๐Ÿ‡ธ USA